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Background:  The 2005 American Heart Association (AHA) Guidelines and the International Liaison Committee on Resuscitation (ILCOR) have 
recommended mild therapeutic hypothermia (32-34°C, 24-48 hours: MTH) for post cardiac arrest syndrome (PCAS) due to ventricular fibrillation 
(VF) (class IIa). But sometimes executing MTH for patients with severe left ventricular dysfunction is not so easy and safe because of hypotension, 
arrhythmias and so on. It is still unknown what temperature is best for low cardiac function patients. So we studied whether slight therapeutic 
hypothermia (35-36°C: STH) is effective and safe compare with MTH for PCAS due to VF.
Methods:  Consecutive PCAS patients who were witnessed, done by-stander cardiopulmonary resuscitation (CPR), confirmed VF caused by cardiac 
or coronary events and introduced therapeutic hypothermia within 3 hours after the return of spontaneous circulation (ROSC) for the latest 15 
months were sorted into the GroupM (34°C, 24-72 hours) and the GroupS (35-36°C, 24-72 hours).The primary end point was a favorable neurologic 
outcome (cerebral performance category: CPC 1 or 2) within 28 days after cardiac arrest. Secondary end points were the rate of complications 
(infections, bleeding, arrhythmias etc.) within fourteen days and the changes of cardiac index (CI) after introducing therapeutic hypothermia.
Results:  Twenty-one patients were studied (GroupM 10 patients and GroupS 11 patients). The rate of favorable neurologic outcome was available 
and did not differ significantly between the two groups (60% vs. 55%, p=0.54). The time to reach target temperature was significantly shorter in the 
GroupS (4.9h vs. 0.9h, p<0.01). Though CI before introducing hypothermia did not differ (2.7 vs. 2.2, p=0.21), the decrease of it was remarkable in 
the GroupM (Δ31% vs. +9.7%, p<0.01). The rate of complications did not differ significantly between them.
Conclusion: Slight therapeutic hypothermia is possibility feasible and safe in patients who were resuscitated after cardiac arrest due to VF with low 
cardiac function.
